H.R. 2821 · 119th Congress

FDA Modernization Act 3.0

Introduced on Apr 10, 2025 by Earl L. "Buddy" Carter (R-GA-1). 41 cosponsors, 21 of them from another party. Latest action (Jul 21, 2026): Received in the Senate.

Stage
Passed one chamber
Introduced
Apr 10, 2025
Cosponsors
41
21 from the other party
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. Reported by committee
  3. Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

To require the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to publish a final rule relating to nonclinical testing methods.

Subjects

  • Administrative law and regulatory procedures
  • Department of Health and Human Services
  • Drug safety, medical device, and laboratory regulation
  • Medical research
  • Research administration and funding

Summary

By the Congressional Research Service (Introduced in House, Apr 10, 2025). Public domain.

FDA Modernization Act 3.0

This bill requires the Food and Drug Administration (FDA) to publish an interim final rule implementing a provision of the Consolidated Appropriations Act of 2023 that authorized the use of certain alternatives to animal testing to support investigational use of a new drug.

The rule must replace references to animal tests, data, studies, models, and research with references to nonclinical tests, data, studies, models, and research throughout the FDA’s regulations governing investigational new drug applications.

The rule must be published within one year of the bill’s enactment, and must take immediate effect as an interim final rule.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Earl L. "Buddy" CarterR-GA-1Sponsor

Democrats · 21

Republicans · 20

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Apr 10, 2025Introduced in House
  2. Apr 10, 2025Introduced in House
  3. Apr 10, 2025 · HouseReferred to the House Committee on Energy and Commerce.
  4. Apr 10, 2026 · HouseReferred to the Subcommittee on Health.
  5. May 13, 2026 · HouseSubcommittee Consideration and Mark-up Session Held
  6. May 13, 2026 · HouseForwarded by Subcommittee to Full Committee by Voice Vote.
  7. May 21, 2026 · HouseCommittee Consideration and Mark-up Session Held
  8. May 21, 2026 · HouseOrdered to be Reported by the Yeas and Nays: 44 - 0.
  9. Jun 18, 2026Reported by the Committee on Energy and Commerce. H. Rept. 119-706.
  10. Jun 18, 2026 · HouseReported by the Committee on Energy and Commerce. H. Rept. 119-706.
  11. Jun 18, 2026 · HousePlaced on the Union Calendar, Calendar No. 614.
  12. Jul 20, 2026 · HouseMr. Guthrie moved to suspend the rules and pass the bill.
  13. Jul 20, 2026 · HouseConsidered under suspension of the rules. (consideration: CR H4639-4640)
  14. Jul 20, 2026 · HouseDEBATE - The House proceeded with forty minutes of debate on H.R. 2821.
  15. Jul 20, 2026Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)
  16. Jul 20, 2026 · HouseOn motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)
  17. Jul 20, 2026 · HouseMotion to reconsider laid on the table Agreed to without objection.
  18. Jul 21, 2026 · SenateReceived in the Senate.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. ANIMAL WELLNESS ACTION6 reports
    $450K reported (all issues)
  2. CONSUMER HEALTHCARE PRODUCTS ASSOCIATION5 reports
    $1.1M reported (all issues)
  3. PERSONAL CARE PRODUCTS COUNCIL5 reports
    $630K reported (all issues)
  4. PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA3 reports
    $9M reported (all issues)
  5. Public Access to SunScreens (PASS) Coalition3 reports
    $280K reported (all issues)
  6. National Association for Biomedical Research1 report
    $30K reported (all issues)

Reports filed in 2025, 2026.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 9, 2026 · loaded Oct 9, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 9, 2026 · loaded Oct 9, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.